Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide 1”

649 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 649 results

Testing effectiveness (Phase 2)Study completedNCT00797823
What this trial is testing

Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone

Who this might be right for
Type 1 Diabetes
Legacy Health System 14
Not applicableStudy completedNCT02006459
What this trial is testing

Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose Disposal

Who this might be right for
Diabetes
University Hospital, Gentofte, Copenhagen 20
Early research (Phase 1)Study completedNCT02673554
What this trial is testing

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 30
Testing effectiveness (Phase 2)Looking for participantsNCT05499702
What this trial is testing

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

Who this might be right for
Type2diabetes
Adrian Vella 20
Not applicableUnknownNCT05268627
What this trial is testing

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Who this might be right for
Obesity
Mansoura University 38
Not applicableStudy completedNCT02181127
What this trial is testing

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

Who this might be right for
Type 1 Diabetes
Massachusetts General Hospital 31
Not applicableStudy completedNCT02509065
What this trial is testing

The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Massachusetts General Hospital 24
Not applicableStudy completedNCT01607931
What this trial is testing

Exercise, Glucose Kinetics, and the Incretin Effect

Who this might be right for
Type 2 Diabetes
Rigshospitalet, Denmark 12
Not applicableStudy completedNCT05889637
What this trial is testing

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 132
Large-scale testing (Phase 3)Study completedNCT02860923
What this trial is testing

Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy

Who this might be right for
CraniopharyngiomasHypothalamic Obesity
University Hospital, Bordeaux 42
Not applicableStudy completedNCT01938469
What this trial is testing

Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery

Who this might be right for
Gastric Bypass SurgeryObesity
St. Luke's-Roosevelt Hospital Center 33
Post-approval studies (Phase 4)Looking for participantsNCT06774079
What this trial is testing

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Who this might be right for
Crohn Disease
University of Miami 24
Early research (Phase 1)Study completedNCT01079624
What this trial is testing

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose

Who this might be right for
PhysiologyGastroenterologyEndocrinology
Uppsala University 15
Not applicableLooking for participantsNCT06725693
What this trial is testing

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Who this might be right for
GLP1-R-related DiseaseTumorInsulinoma+1 more
Tianjin Medical University 500
Large-scale testing (Phase 3)Study completedNCT00694122
What this trial is testing

Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon

Who this might be right for
Type 1 DiabetesDawn Phenomenon
Massachusetts General Hospital 27
Not applicableStudy completedNCT05076292
What this trial is testing

Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycemia
Steno Diabetes Center Copenhagen 22
Post-approval studies (Phase 4)Study completedNCT01461577
What this trial is testing

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 89
Not applicableStudy completedNCT02994420
What this trial is testing

Endocrine and Neural Control of Eating in Women

Who this might be right for
Normal Body WeightObesity
University of Zurich 50
Not applicableLooking for participantsNCT06424015
What this trial is testing

Insulin and Insulin Pulses During Fasting

Who this might be right for
PreDiabetes
Mayo Clinic 60
Not applicableLooking for participantsNCT06647368
What this trial is testing

Development of a Non-invasive Method for Quantifying Cerebral Glucose Metabolism for Studying the Effect of Glucagon in Humans

Who this might be right for
Cerebral Glucose Metabolism
Nicolai Jacob Wewer Albrechtsen 6
Load More Results